Impairment of calcium mobilization in phagocytic cells in glycogen storage disease type 1b
- PMID: 8319725
- DOI: 10.1007/BF02072086
Impairment of calcium mobilization in phagocytic cells in glycogen storage disease type 1b
Abstract
Patients with glycogen storage disease (GSD) type 1b, in contrast to patients with GSD 1a, are susceptible to recurrent bacterial infections suggesting defective phagocytic function. We have demonstrated a selective defect in respiratory burst activity but not in degranulation by phagocytic cells in GSD 1b but not in GSD 1a. The respiratory burst abnormality in phagocytic cells from GSD 1b patients was associated with impaired calcium mobilization, whereas these processes were normal in GSD 1a patients. Therefore, the alteration in calcium mobilization was an indication of a signalling defect in phagocytic cells from GSD 1b. However, calcium mobilization was normal in lymphocytes, indicating that defective calcium mobilization was not a global finding in circulating leukocytes, but was specific to phagocytic cells. Calcium mobilization in response to ionomycin was reduced suggesting decreased calcium stores in GSD 1b neutrophils. Therefore, altered phagocytic cell function in GSD 1b patients appears to be associated with diminished calcium mobilization and defective calcium stores. This defective calcium signalling was associated with a selective defect in respiratory burst activity but not degranulation.
Similar articles
-
Impaired metabolic function and signaling defects in phagocytic cells in glycogen storage disease type 1b.J Clin Invest. 1990 Jul;86(1):196-202. doi: 10.1172/JCI114684. J Clin Invest. 1990. PMID: 2164043 Free PMC article.
-
Interferon-gamma corrects the respiratory burst defect in vitro in monocyte-derived macrophages from glycogen storage disease type 1b patients.Pediatr Res. 1993 Sep;34(3):265-9. doi: 10.1203/00006450-199309000-00005. Pediatr Res. 1993. PMID: 8134165
-
In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization.Pediatr Res. 1994 Jan;35(1):84-90. doi: 10.1203/00006450-199401000-00017. Pediatr Res. 1994. PMID: 7510873
-
Defective neutrophil and monocyte functions in glycogen storage disease type Ib: a literature review.Eur J Pediatr. 1993;152 Suppl 1:S33-8. doi: 10.1007/BF02072085. Eur J Pediatr. 1993. PMID: 8391445 Review.
-
Immune deficiency in glycogen storage disease type 1B.Isr J Med Sci. 1996 Dec;32(12):1276-81. Isr J Med Sci. 1996. PMID: 9007171 Review.
Cited by
-
The chemopreventive properties of chlorogenic acid reveal a potential new role for the microsomal glucose-6-phosphate translocase in brain tumor progression.Cancer Cell Int. 2006 Mar 27;6:7. doi: 10.1186/1475-2867-6-7. Cancer Cell Int. 2006. PMID: 16566826 Free PMC article.
-
Mycobacterial growth and sensitivity to H2O2 killing in human monocytes in vitro.Infect Immun. 1997 Nov;65(11):4850-7. doi: 10.1128/iai.65.11.4850-4857.1997. Infect Immun. 1997. PMID: 9353075 Free PMC article.